Acceleron Pharma Inc. XLRN
Set alert
As of Apr 24, 3:47 PM ET
52-week range unavailable
- Open
- 179.85
- Prev close
- 178.75
- Mkt cap
- 0
- Vol
- 7.88M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 177.20
- High
- 179.85
- Forward P/E
- -54.17
- Beta
- 0.00
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2021
- 50-d avg
- 169.49
- 200-d avg
- 137.95
- 1y target
- 178.88
News
4 years ago investors.com
Merck Scores A 'Must-Win' For Its $11.5 Billion Acceleron Buyout
Merck stock jumped Monday after a drug its acquired for billions scored a "must-win" in patients with a rare blood pressure condition. The post Merck Scores A 'Must-Win' For Its $11.5 Billion…
4 years ago businesswire.com
Avoro Capital Urges Acceleron Shareholders Not to Tender Into Merck's Inadequate Offer
NEW YORK--(BUSINESS WIRE)--Avoro Capital Advisors (“Avoro”), a long-term and collaborative investor in life sciences and biotechnology companies, together with certain of its affiliates and managed…
4 years ago fool.com
Is Merck's Planned Acquisition of Acceleron in Trouble?
There's nothing to worry about with a recent delay.
4 years ago businesswire.com
Avoro Capital Releases Presentation Detailing Why Acceleron Shareholders Should Not Tender Into Merck's Inadequate Offer
NEW YORK--(BUSINESS WIRE)--Avoro Capital Advisors (“Avoro”), a long-term and collaborative investor in life sciences and biotechnology companies, together with certain of its affiliates and managed…
-
4 years ago benzinga.com
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
Here's a roundup of top developments in the biotech space over the last 24 hours:
4 years ago zacks.com
Acceleron Pharma (XLRN) Reports Q3 Loss, Lags Revenue Estimates
Acceleron (XLRN) delivered earnings and revenue surprises of 1.04% and -6.62%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
4 years ago businesswire.com
Acceleron Reports Third Quarter 2021 Financial Results
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron Pharma Inc. (Nasdaq:XLRN), a biopharmaceutical company dedicated to the discovery, development, and commercialization of TGF-beta superfamily therapeutics…
5 years ago prnewswire.com
SHAREHOLDER ALERT: WeissLaw LLP Reminds DWSN, PAE, XLRN, and FLXN Shareholders About Its Ongoing Investigations
NEW YORK, Nov. 1, 2021 /PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights…
5 years ago benzinga.com
Merck Pushes Acceleron Buyout By Refiling For Antitrust Review
Merck & Co Inc (NYSE: MRK) revealed that it had temporarily withdrawn its premerger notification and report form. The company said it plans to refile today.
5 years ago businesswire.com
Avoro Capital Issues Open Letter to Fellow Acceleron Pharma Shareholders
NEW YORK--(BUSINESS WIRE)--Avoro Capital Advisors (“Avoro”), a long-term and collaborative investor in life sciences and biotechnology companies, beneficially owns approximately 7% of Acceleron…
5 years ago businesswire.com
Acceleron Announces Third Quarter 2021 REBLOZYL® Net Sales
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron Pharma Inc. (Nasdaq:XLRN), a biopharmaceutical company dedicated to the discovery, development, and commercialization of TGF-beta superfamily therapeutics…
5 years ago prnewswire.com
SHAREHOLDER ALERT: WeissLaw LLP Reminds MDP, GWB, XLRN and HFC Shareholders About Its Ongoing Investigations
NEW YORK, Oct. 22, 2021 /PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights…
5 years ago benzinga.com
Bristol Myers Pledges To Offload Acceleron Shares: Bloomberg
Bristol-Myers Squibb Co (NYSE: BMY) is planning to tender its shares in Acceleron Pharma Inc (NASDAQ: XLRN) after Merck & Co Inc (NYSE: MRK) agreed to buy the biotechnology company for $11.5 billion,…
5 years ago businesswire.com
Darwin Global Urges Acceleron Shareholders Not to Tender Their Shares to Merck
JERSEY, Channel Islands--(BUSINESS WIRE)--Darwin Global Management Limited (“Darwin Global”), a long-term investor in the biotechnology and pharmaceutical sector and beneficial owner of 2,345,620…
5 years ago businesswire.com
ACCELERON PHARMA ALERT: Investors Should Contact Bragar Eagel & Squire, P.C. Over Tender Offer for XLRN Shares
NEW YORK--(BUSINESS WIRE)-- #Acceleron--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the officers or directors of…
5 years ago prnewswire.com
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Acceleron Pharma Inc. - XLRN
NEW YORK, Oct. 13, 2021 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018-2020 ISS Securities Class…
5 years ago reuters.com
Holocene Advisors says Merck's offer undervalues Acceleron
Investment management firm Holocene Advisors said it will not tender its shares in Acceleron Pharma Inc into Merck & Co's proposed $180 per share offer for the drugmaker, as it significantly…
5 years ago businesswire.com
Holocene Advisors Believes Merck's Proposed Offer of $180 Per Share for Acceleron Significantly Undervalues Company
NEW YORK--(BUSINESS WIRE)--Holocene Advisors, LP (“Holocene”), a fundamental investment management firm and significant shareholder of Acceleron Pharma Inc. (Nasdaq: XLRN) (“Acceleron” or the…
5 years ago fool.com
Is an Acquisition of Acceleron a Smart Move for Merck?
Merck will pick up a promising pipeline candidate with the deal.
5 years ago newsfilecorp.com
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of the Merger of Acceleron Pharma Inc. with Merck & Co., Inc.
New York, New York--(Newsfile Corp. - October 4, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All Persons or Entities who purchased Acceleron Pharma Inc. (NASDAQ:…
5 years ago forbes.com
With Acceleron Acquisition Merck Stock Is Likely To See A Multiple Revision
Merck yesterday announced that it will acquire Acceleron Pharma - a biopharmaceutical company focused on rare diseases - for $11.5 billion funded in cash and debt. Acceleron has multiple potentially…
-
5 years ago benzinga.com
Earnings Scheduled For August 5, 2021
Companies Reporting Before The Bell • OneSpaWorld Holdings (NASDAQ:OSW) is projected to report quarterly loss at $0.20 per share on revenue of $6.42 million.
-
5 years ago benzinga.com
Earnings Scheduled For May 6, 2021
Companies Reporting Before The Bell • ViacomCBS (NASDAQ:VIAC) is projected to report quarterly earnings at $1.22 per share on revenue of $7.30 billion.
-
5 years ago benzinga.com
Benzinga's Top Ratings Upgrades, Downgrades For March 23, 2021
Benzinga's Top Ratings Upgrades, Downgrades For March 23, 2021
-
5 years ago benzinga.com
52 Weeks High Article 0.7186450125908432
Stocks That Hit 52-Week Highs On Monday Before 10 a.m. ET on Monday, 136 companies hit new 52-week highs.
-
5 years ago benzinga.com
Earnings Scheduled For February 25, 2021
Companies Reporting Before The Bell • PG&E (NYSE:PCG) is likely to report quarterly earnings at $0.23 per share on revenue of $4.78 billion.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Monday
During Monday's morning trading, 285 companies set new 52-week highs.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Friday
Friday's session saw 466 companies set new 52-week highs.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Monday
Monday's morning session saw 240 companies set new 52-week highs.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Wednesday
Before 10 a.m. ET on Wednesday, 322 companies hit new 52-week highs.
-
5 years ago benzinga.com
Earnings Scheduled For November 5, 2020
Companies Reporting Before The Bell • Bluerock Residential Growth REIT, Inc. Class A Common Stock (AMEX:BRG) is expected to report quarterly loss at $0.64 per share on revenue of $52.59 million.
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Tuesday
On Tuesday, 105 companies achieved new highs for the year.
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Monday
This morning 239 companies reached new 52-week highs.
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Friday
This morning 221 companies reached new 52-week highs.
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Tuesday
On Tuesday, 154 stocks made new 52-week highs.
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Tuesday
Tuesday morning saw 85 companies set new 52-week highs.
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Thursday
During Thursday's morning session, 55 companies made new 52-week highs.
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Tuesday
During Tuesday's morning trading, 41 companies set new 52-week highs. Stocks that set new 52-week highs during the first half-hour of trading on Tuesday are as follows:
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Tuesday
Stocks That Hit 52-Week Highs On Tuesday
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Tuesday
Stocks That Hit 52-Week Highs On Tuesday
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Monday
Stocks That Hit 52-Week Highs On Monday
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Friday
Stocks That Hit 52-Week Highs On Friday
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Tuesday
Stocks That Hit 52-Week Highs On Tuesday
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Thursday
Stocks That Hit 52-Week Highs On Thursday
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Friday
Stocks That Hit 52-Week Highs On Friday
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Thursday
Stocks That Hit 52-Week Highs On Thursday
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Friday
Stocks That Hit 52-Week Highs On Friday
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Wednesday
Stocks That Hit 52-Week Highs On Wednesday
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Tuesday
Stocks That Hit 52-Week Highs On Tuesday
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Tuesday
Stocks That Hit 52-Week Highs On Tuesday